←Back to Expert Scholars
Translational Medicine / 转化医学Pan RAS Inhibitors
Frank McCormick
PhD
🏢University of California San Francisco🌐USA
Professor
130
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Frank McCormick is a founder of the NCI RAS Initiative and has shaped the field of RAS drug discovery for decades. His work spans pan RAS targeting, isoform specific strategies, and downstream pathway inhibition. He continues to drive translational development of RAS directed therapies.
Share:
🧪Research Fields 研究领域
RAS
signal transduction
drug discovery
NF1
cancer biology
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Frank McCormick 的研究动态
Follow Frank McCormick's research updates
留下邮箱，当我们发布与 Frank McCormick（University of California San Francisco）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment